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ABSTRACT
The use of contraception has afforded many women the opportunity to gain
control over their reproductive health while also advancing their education and career
goals. Additionally, hormonal contraceptives have improved women’s quality of life by
treating and preventing specific clinical symptoms and conditions. Nonetheless,
disparities and barriers to accessing affordable reproductive care still affect many
populations of women. This study examines the accessibility and affordability of
contraception for women’s reproductive and self-care needs, including treating and
preventing clinical symptoms, conditions, and pregnancy. A literature review of PubMed
databases was completed for studies in the United States between January 2013 and May
2021. Studies were chosen based on examining the perceptions, barriers, and advantages
of acquiring accessible and affordable hormonal contraception on women’s health.
Though many women benefit from contraceptive use throughout various stages of their
lives, specific populations of women experience disparities and barriers to accessing
quality and affordable reproductive care. Many of these barriers include lack of
knowledge, patient-provider power dynamics, desire for autonomy in one’s reproductive
health, insurance or cost constraints, and additional policies and actions restricting
reproductive and contraceptive care availability. Expanding women-focused education,
services, and policies to address these barriers systematically can improve the
accessibility and affordability of contraceptive and reproductive care and enhance the
quality of women’s health and self-care.
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INTRODUCTION
Women have faced many challenges in accessing quality and affordable health
care for centuries. Women’s health is defined as the promotion, maintenance, and
restoration of the physical, psychological, social, and numerous other concerns that affect
women’s well-being (1). Major issues previously affecting women’s health included
increased health premiums and denial or lack of coverage for essential services, including
maternal care, mental health care, and prescriptions for contraceptives (1). The Women’s
Health Movement sparked initial changes to address the gaps in women’s health by
providing women control over their reproductive rights, including women as key players
in clinical research and increasing awareness of the worldwide violence and
discrimination against women (1). Over the years, federal policies regarding women’s
health care have shifted. Implementation of the Affordable Care Act in 2014 expanded
coverage for reproductive-aged women to improve health insurance coverage and limit
cost-related barriers. Nonetheless, there continue to be prevalent risks to accessing
quality and affordable preventative and reproductive services for many women.
Contraception methods have been a critical preventative health service used to
reduce unintended pregnancies over the years. Contraceptive use has contributed to
improving women’s self-care and well-being, providing autonomy in making decisions
about one’s health, and positively impacting families, communities, and society. Types of
contraceptive methods are divided into hormonal contraceptives and nonhormonal
contraceptives for protective measures and emergency contraceptives used after sexual
intercourse. Nonhormonal contraceptives include condoms, vaginal sponges, and
diaphragms. Hormonal contraceptive methods include the pill, patch, ring, and
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injectables, categorized as either combined estrogen-progestin or progesterone-only.
Another method of hormonal contraceptives includes long-acting reversible contraception
(LARC), which involves hormonal implant devices. The efficacy of these contraceptive
methods to prevent unintended pregnancies is highest with either the LARC, combined
estrogen-progestin, or progesterone-only methods (2). The nonhormonal methods are the
least efficient (2).
In 2018, more than 99% of sexually active women between the ages of 15 to 44
reported using some form of contraception in their lifetime (2). Various contraceptive
methods have contributed to women’s societal advancement by limiting unwanted
pregnancies while prioritizing their own needs and desires, such as achieving their
education and career goals. Though contraceptive use has decreased the rates of live
births, unintended pregnancies, and abortions in the United States, these rates remain
relatively high compared to similar countries. Significant reproductive health disparities
are still present among women of color, women with low incomes, and women aged 18
to 24 (3). These women often face difficulties with the accessibility and affordability of
quality healthcare.
Though women have made many improvements historically in the fight for equal
rights, there are still many restrictions limiting women’s rights to reproductive care. The
focus of this review is to address the advantages, barriers, constraints, and disparities of
acquiring accessible and affordable hormonal contraceptives to improve the quality and
availability of services for women’s self-care and reproductive health.
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BACKGROUND
In addition to protecting from unintended pregnancies, hormonal contraceptives
have been known to treat and prevent gynecological conditions in women. The combined
estrogen-progestin oral contraceptive pill was initially introduced to treat menstrual
symptoms, such as migraines, excess menstrual blood loss, dysmenorrhea, and
premenstrual syndrome (2). Recent studies have found evidence of the treatment of
various conditions and symptoms specific to women with combined estrogen-progestin
and LARC methods. These hormonal contraceptives have also been found to treat
menorrhagia and acne symptoms while also preventing the development of ovarian
cancer, uterine fibroids, endometriosis, and pelvic inflammatory disease (2).
However, the need for accessible and affordable hormonal contraceptives for the
self-care of young women, postpartum women, and perimenopausal women is often
overlooked. Many young women, including adolescents, experience a high rate of
unintended pregnancies. The reasons for the high rate of young pregnancies include the
inability to access effective preventative care, limited disclosure of sexual status, and lack
of knowledge about reproductive health and contraception options (4). The postpartum
period is ideal for women to initiate contraception to reduce the risk of short birthing
intervals, which can cause preterm birth and low birth weights in newborns (5). Many
women experience changes during the perimenopausal period, including fertility issues,
urogenital changes, and abnormal bleeding. Contraceptive use during the perimenopausal
period can relieve these symptoms and treat problems such as loss of bone mineral
density, irregularities in menstruation, and vasomotor instability, which causes hot
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flashes (5). The acquisition and continuation of hormonal contraception have provided
many benefits to improving women's quality of life and self-care at every stage.
The knowledge and use of contraceptives give women the power to exert agency
and advocate for themselves, their future, and their children. Many women have varying
perceptions and satisfaction of different hormonal contraception methods. A prospective
cohort study of 5,000 women found 84% satisfied with the LARC method compared to
53% that used other hormonal contraceptive methods (6). Factors that influence women’s
satisfaction include ease of use, improvements in bleeding and cramping patterns,
perceived effectiveness, and limited side effects (6). However, a large proportion of
women have negative perceptions of hormonal contraception. The most influencing
factors contributing to women’s negative perception of hormonal contraception are cost,
provider bias, lack of provider knowledge or training, and accessibility barriers (7).
Barriers to Affordable and Accessible Contraception for Women
Healthcare providers play an essential role in educating and promoting the health
benefits of contraceptive care while enabling open, patient-centered communication
concerning the unique demands of each woman’s health. Unfortunately, many women’s
misperceptions and unfounded concerns surrounding hormonal contraceptive use are
often enabled by their healthcare providers’ lack of knowledge about the various
methods. Many women prefer to use family planning services that offered LARC
methods compared to other hormonal contraceptives (8). Notably, the LARC method has
the highest satisfaction and effectiveness of use. Still, barriers such as provider
knowledge gaps, prohibiting same-day insertion, and the elimination of immediate
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insertion for postpartum women have affected their continuation of use (9). Though 88%
of physicians report providing long-acting hormonal contraceptives, 24% of internal
medicine or pediatric physicians also prescribe and provide these methods (9). This may
be due to the long-term cost of LARC methods being lower than the long-term cost of
monthly refills for pills, patches, or injectables. However, the upfront cost of LARC
methods is more costly than other hormonal contraceptive methods (9). Primary care
physicians are the first-line providers for many women as compared to obstetriciangynecologist. However, very few residency programs adequately train students of
different specialties in counseling, prescribing, and providing hormonal contraceptives
(2). A primary care physician will often refer a patient to an obstetrician-gynecologist to
provide contraception counseling or insert a contraceptive device. It would be beneficial
to patients to have primary care specialists also educated, trained and confident in
counseling women on reproductive health and contraceptive options, following the
guidance of the CDC’s Medical Eligibility Criteria (2).
Significant barriers obstruct the affordability and accessibility of effective
women’s reproductive healthcare and contraceptive acquisition. In 2014, the Affordable
Care Act required all private insurance plans to cover all FDA-approved hormonal
contraceptive methods with no out-of-pocket costs. The expansion of Medicaid and
private insurance decreased the proportion of uninsured women from 18.9% in 2012 to
11.5% in 2015, with little to no changes today (10; 11). Despite the Affordable Care
Act’s influence to reduce disparities in women’s health coverage by expanding Medicaid
and private coverage for women of reproductive age, costs of hormonal contraception for
women’s self-care needs remain a significant barrier. Though insurance companies cover
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all approved contraceptive methods, coverage varies depending on state and insurer.
Insurance barriers, such as a lack of coverage, cost-sharing, and limiting the number of
products dispersed at a time, cause significant constraints and often lead to
discontinuation of hormonal contraceptive use (12). The American College of
Obstetricians and Gynecologists recommends that payment policies support providing 313 month supplies of oral contraceptives to maintain the individual continuation of use
(12). These barriers pose a challenge to many women as it may become difficult to
maintain routine administration or demanding to access a provider to get a new
prescription.
Additionally, cost-sharing varies between insurance coverage plans. Individual
plans with high out-of-pocket costs, deductibles, and copayments can be barriers to
accessing and maintaining contraceptive services. Previous findings suggest lower costsharing can increase the use of effective contraceptive methods (13). Even with
reproductive care covered by publicly and privately owned insurance plans, women still
pay 60% out-of-pocket costs for contraception methods compared to 33% for noncontraceptive drugs (12).
Though the Accessible Care Act of 2014 increased insurance coverage for
women’s health and preventative care, women saw little to no change in their ability to
access care. Several structural barriers limit women’s accessibility to contraceptive care.
Contraceptive services often require an annual physician visit to be screened, counseled,
get a prescription, then obtain the chosen contraceptive method, frequently from a
pharmacy. The requirement for annual medical screenings and multiple provider visits is
sometimes a deterrent for many women, often supported by some insurer payment
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policies (12). Though physician screenings and counseling are beneficial to assist
individuals in making the best decision to initiate contraceptive use depending on their
health status, annual pelvic examinations and cervical cytology can discourage a woman
from continuing the use of a particular method. Some providers also refuse same-day
services for contraceptives, such as LARC and other hormonal methods, to acquire a
pregnancy test before inserting the implant device. However, there are instances in which
a pregnancy test is not needed, such as when the last menstruation was less than seven
days ago or if a patient has not had unprotected sex since the last menstrual cycle (9).
Additionally, inconvenient office hours, a limited range of method knowledge, and
availability also pose a challenge for women accessing or continuing contraceptive care.
Expanding women’s access to reproductive and contraceptive care by removing the
financial and structural barriers to access providers and clinics should continue to be an
important goal of women’s health while also ensuring women’s preferences and desires
are the focus.
Additionally, federal, state, and local restrictive policies and legislature interfere
with the provision and coverage surrounding the accessibility and affordability of
contraception and reproductive services. The Affordable Care Act of 2014 aimed to
improved coverage for essential women’s health services; however, specific coverage
exclusions continue to prevent women from receiving quality and affordable preventative
and reproductive services (14). In 2018, Trump also released two rulings allowing
exemptions for employees in covering women’s contraceptive care due to religious
beliefs or nonreligious moral objections (15). These unfavorable rulings act to interfere
with women’s access to contraceptive services and the patient-physician relationship.
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Minors are currently restricted in 20 states from acquiring contraceptive services even
with parental consent (12). Conversely, the American College of Obstetricians and
Gynecologists recommends and supports accessible and affordable women’s health and
contraceptive care for all (12).
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RESEARCH STRATEGIES
A literature review of the PubMed database was conducted to review articles and
studies in the United States between January 2013 to May 2021. The studies sampled or
examined experiences of reproductive-aged women 15 to 44 years old. Studies were
chosen based on examining the benefits, perceptions, difficulties, and challenges
affecting the accessibility and affordability of women’s reproductive health regarding
acquiring hormonal contraceptives. To select studies, a keyword search, with Boolean
phrases AND/OR, was used involving the following terms: female, women, women’s
health, contraception, contraceptives, health care, preventative care, women’s self-care,
self-care, access, accessibility, hormonal contraception, reproductive health, health
service, reproductive health service, women’s health care, affordability, cost, women’s
preventative care, insurance barriers, insurance constraints, policies, laws, Affordable
Care Act. Additional phrases searched included: challenges in access, barriers in access,
improvements in access, challenges in affordability, barriers in affordability,
improvements in affordability, challenges in cost, barriers in cost, improvements in cost.
No hard copy journal searches were conducted. Criteria for inclusion included women of
reproductive age, a focus on women’s health beyond protecting from unintended
pregnancies, and facilitating or limiting factors affecting accessible and affordable
acquisition of contraceptives for women’s self-care and reproductive health. Recent
advancements and innovations to accessing affordable contraceptive care were also
searched and reviewed to improve women’s health.
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DISCUSSION
The affordability and accessibility of health services for women’s reproductive
health and self-care have progressed over the years. Nonetheless, many improvements are
still necessary. The implementation of the Affordable Care Act of 2014 expanded
coverage for women’s preventative health services, which included contraceptive
counseling and care. Unfortunately, many women still deal with increased out-of-pocket
spending, cost-sharing effects, and obstacles to accessing reproductive health services.
There is also a need to improve provider knowledge deficits to counsel women in
choosing a safe contraceptive method under the U.S. Medical Eligibility Criteria for
Contraceptive Use guidelines. Obstetrician gynecologists, internal medicine providers,
and pediatricians can be strong advocates for safe, affordable contraceptive access. As
women require different health resources throughout their lifetime to maintain power
over their health and lives, open, patient-centered communication and care should be
supported to enable women to make informed choices about their reproductive and selfcare health maintenance.
To Improve the Affordability of Hormonal Contraceptives
The expansion of insurance plans to cover all FDA-approved contraceptive
methods may have assisted in coverage for many women’s preventative care services;
however, out-of-pocket costs did not change. Privately insured women saw an increase
in out-of-pocket expenses due to cost-sharing effects (13). In contrast, publicly insured
women, such as those under Medicaid, saw decreased out-of-pocket costs (13). Women
already face increased financial challenges due to low incomes. Being burdened by
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increased out-of-pocket costs is another way to limit the power women have over their
health. Though the Affordable Care Act seemed effective in transferring some of the cost
burdens away from women, it may be a while before cost-sharing is eliminated.
Studies have shown women, insured and uninsured, still face burdens being able
to afford specialist care, prescription medications, screenings, multiple visits, and annual
STD and pelvic examinations (16). Health policies, organizations, and insurance
companies should eliminate cost-sharing to obtain women’s reproductive and self-care
services. Diminishing cost-sharing has the potential to lead to increased contraceptive
continuation. A lower out-of-pocket cost may also be the difference between choosing a
contraceptive method over another and considering personal lifestyle and health status.
Diminishing copayments, high deductibles, and coinsurance for comprehensive
contraceptive services and prescriptions may increase adherence to contraceptive use for
women’s reproductive and self-care maintenance.
To Improve the Accessibility of Hormonal Contraceptives
Expanded access to affordable preventative care has contributed to many benefits
for women’s health; however, threats to comprehensive reproductive services still exist.
In 2020, there was an increase in women who saw or talked to a physician in the past 12
months (16). Nonetheless, gaps in access to quality reproductive care are still a barrier to
overcome. Providers should be educated in counseling, prescribing, and providing
contraceptive options to women of all ages. There should be increased access to newer,
safer formulations for oral contraceptive methods and an increase in the availability of
LARC methods (17). Minority and low-income women have often been prescribed
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LARC methods without regard to their personal health histories or status (17). Physician
training programs and organizations should aim to overcome provider bias in the
counseling and providing of hormonal contraceptives and instead consider individual
women’s unique health needs and desires for reproductive and self-care.
Access to contraception should be universally unrestricted by the government to
improve the quality of life for women throughout their lifespan. New legislation, enacted
in 2017, has expanded access to contraception in 22 states plus Washington, D.C., to
provide a year-long supply of all forms of self-administered hormonal contraceptive
methods (18). This law aimed to increase method continuation, including the provision
and use of combined and progestin-only oral contraceptive pills, the vaginal ring, and the
patch (18). There remain obstacles in the full implementation of this law, such as store
policies and insurance reimbursement challenges, that must be addressed. Patients,
providers, and prescribers must be informed of this new law to advocate for the
development of new protocols and personnel training in pharmacies and insurance
companies (18). Overall, all women have the right to affordable and accessible health
services without restriction from the government or insurance companies for self-care
and reproductive health throughout various stages of their life span to maintain optimal
health and achieve personal goals.
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RECOMMENDATIONS FOR FUTURE STUDIES
Future studies should take into account the deficits in research considering
expanding access to adolescents, strengthening insurance coverage, access and
affordability, and the implications of recent innovations on these factors. Expanding
access to hormonal contraceptives for adolescents holds many benefits. Adolescents are
often overlooked in research and policy implementation surrounding hormonal
contraceptive use. Minors should be included in the research, design, and implementation
of expanded hormonal contraceptive options (4). Additionally, advocacy to expand
adolescent access to hormonal contraceptives is necessary if increased access
significantly benefits this population.
The effects of the Affordable Care Act related to coverage, access, and
affordability of comprehensive women’s reproductive health are also critical. There are
many gaps in research regarding the continuation of services for minority communities,
the impact of eliminating cost-sharing, and patient-focused outcomes. There is also a
need to assess the impact of the Affordable Care Act’s expansion on contraceptive brand
use. Because the Act does not mandate insurance companies cover all contraception
brands, the choice of a brand could determine an individual’s out-of-pocket cost for
services (13). An analysis on subgroups that experience the most disparities in care and a
comparison analysis of private insurers to public insurers concerning contraceptive use
and continuation patterns is also lacking in research (16). Overall, improvements in the
policies and stability of insurance plans by expanding Medicaid in all states and
maintaining the Marketplace supports strengthening the accessibility and affordability of
contraceptives for women’s reproductive care.
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Additionally, a debate to implement new methods to expand affordable and
accessible contraceptive care has been discussed. Several innovations to increase
contraceptive access for women of all ages are being developed, such as over-the-counter
oral contraceptives, pharmacist prescribing, and web-based telehealth platforms (4).
State-to-state variability in insurance plans, pharmacy prescribing, and telehealth laws are
just some barriers to implementing these innovations to accessible contraceptive care.
Many measures must be considered before implementation of over-the-counter
access to hormonal contraception begins. Products dispensed over-the-counter must have
a low potential for misuse and abuse and limit the potential consequences for
inappropriate self-selection. Over-the-counter access will likely begin with progestinonly pills, not combined oral contraceptives, due to their safety and low side effects
profile (4). There is currently a lack of legislative mandates, policies, and financial
incentives for insurance companies to implement over-the-counter access to hormonal
contraceptives (19). There is also concern that this method may reduce the need for
routine preventative screenings, such as pap smears, pelvic exams, breast exams, and
sexually transmitted infections and disease screenings (20). Though adolescents are in
support of over-the-counter access, many adults oppose this option for minors.
In the past five years, there has been an expansion in state legislature allowing
pharmacists to prescribe hormonal contraceptives (4). This innovation allows for
increased access to contraceptive services with pharmacists counseling, screening for
contraindications, and prescribing an appropriate hormonal contraceptive method for use.
This method is also not supported for adolescent access, as adolescents tend to overreport contraindications without official diagnosis (4). There are many barriers to the
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enactment of this innovation. They include a lack of standard protocols, a negative
impact on pharmacy workflow, and patient materials not suitable for minors (21).
Additional threats include the requirement for a different skill set compared to a
traditional pharmacist and an inability to provide private counseling due to limited space.
One method to overcome these barriers is the use of collaborative drug therapy
management. This program involves a collaborative agreement between physicians and
pharmacists granting pharmacists professional responsibility for many roles (4). Further
studies involving this method may prove beneficial to increasing access and continuation
of hormonal contraceptive methods.
Laws regarding what services can be accessed through telehealth services also
varies from state to state. Telehealth services have the ability to increase access to
women’s reproductive health and contraceptive services. Women of all ages are able to
safely be screened and consulted by a physician before being prescribed a particular
contraceptive method for use (4). Many companies and health organizations currently
provide telehealth services for prescription hormonal contraceptives. Significant reasons
for promoting telehealth expansion for contraceptive and women’s health services
include ease of online service, inability to get an appointment with a provider, and a need
for confidentiality.
Overall, women face many obstacles in obtaining affordable and accessible
contraception for women’s reproductive and self-care needs. Structural barriers, coverage
barriers, and political barriers limit women’s ability to have power and autonomy over
their health achieving future goals. Reducing the barriers to affordable and accessible
contraceptive services while also making strides to address the gaps in research has the
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ability to improve women’s confidence in initiating and continuing the use of hormonal
contraceptives for reproductive and self-care maintenance.
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